Small cap movers: Abingdon Health and MyHealthChecked reap rewards from the fight against COV ID-19

0 8
Throughout the pandemic, any company involved with some sort of COVID-19 remedy or precautionary device seemed to enjoy a share price boost and that is still happening judging by the share price performance of Abingdon Health PLC. The developer and manufacturer of rapid medical tests shot 89% higher after it announced the launch of BioSURE COVID-19 IgG Antibody Self Test. Last month, Abingdon announced that it had signed an exclusive manufacturing agreement with BioSure, a UK company specialising in the provision of rapid in-vitro diagnostic testing solutions, including self-testing. Abingdon said the BioSure product is now being manufactured. Case two: MyHealthChecked PLC, the consumer home-testing healthcare company. Its shares jumped 51% after it drew investors’ attention to an announcement from the Department of Health and Social Care that private COVID-19 testing companies will be removed from the GOV.UK list if they advertise misleading prices. 82 providers, ma
Subscribe or log in to read the rest of this content.
Leave A Reply

Your email address will not be published.

At The Centre of Every Trade